REGENXBIO Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
REGENXBIO Inc
TickerRGNX
CIK #0001590877
CUSIP75901B107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address9712 Medical Center Drive Suite 100, Rockville, MD 20850
Source [EDGAR]
CIK Filing 2011 - 2024
[0001590877] 10-K
[0001590877] 10-Q
[0001590877] 3
[0001590877] 4
[0001590877] 5
[0001590877] 8-K
[0001590877] D
[0001590877] SC 13D
[0001590877] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
GIC Private Ltd REGENXBIO Inc [2023-04-07] 5.1
JPMorgan Chase & Co REGENXBIO Inc [2021-01-15] 6.7
GIC Private Ltd REGENXBIO Inc [2020-03-06] 5.6
State Street Corp REGENXBIO Inc [2020-02-14] 5.09
Redmile Group LLC REGENXBIO Inc [2020-02-14] 6.8
REGENXBIO Inc Prevail Therapeutics Inc [2020-02-13] 5.95
State Street Corp REGENXBIO Inc [2019-02-13] 5.5
Vanguard Group Inc REGENXBIO Inc [2019-02-12] 9.45
RTW Investments LP REGENXBIO Inc [2017-10-05] 5.0
Venrock Healthcare Capital Partners LP REGENXBIO Inc [2016-02-16] 4.1
FMR LLC REGENXBIO Inc [2015-09-25] 0.0
Kiser 2012 Gift Trust REGENXBIO Inc [2015-09-25] 9.0
Allan M Fox Trust U/A/D April 21 2015 REGENXBIO Inc [2015-09-25] 12.7
Brookside Capital Partners Fund LP REGENXBIO Inc [2015-09-24] 6.69
Flynn James E REGENXBIO Inc [2015-09-22] 0.33
Form 3/4/5 Filer 2011 - 2024
REGENXBIO Inc.
Zachary Jennifer
Fox Allan M.
Tasse Daniel
Stump David C
Migausky George V
Glucksmann Alexandra
Karabelas Argeris N
Bennett Jean
Vasista Vittal
Danos Olivier
Simpson Curran
Pakola Steve
Mills Kenneth T.
Christmas Patrick J.
Beshar Luke M
Abdun-Nabi Daniel
Hayden Donald J Jr
Yoo Stephen
Samuels Camille D
FMR LLC
Ali Faraz
Engleman Edgar
Flynn James E
Deerfield International Master Fund, L.P.
Deerfield Mgmt L.P.
Deerfield Management Company LP Series C
Deerfield Mgmt III, L.P.
Deerfield Private Design Fund III, L.P.
Deerfield Partners LP
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 7,727,210.0 8,040,790.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 4,245,601.0
JPMorgan Chase & Co [2023-03-31] DFND 3,647,733.0 4,005,623.0
State Street Corp [2023-03-31] DFND 2,491,970.0 2,581,263.0
Redmile Group LLC [2023-03-31] SOLE 1,640,725.0 1,640,725.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 1,383,514.0 1,435,315.0
Aquilo Capital Management LLC [2023-03-31] SOLE 831,014.0 831,014.0
Citadel Advisors LLC [2023-03-31] DFND 764,957.0 764,957.0
Geode Capital Management LLC [2023-03-31] DFND 760,797.0 760,797.0
Millennium Management LLC [2023-03-31] SOLE 719,211.0 719,211.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 559,646.0 632,378.0
Bioimpact Capital LLC [2023-03-31] SOLE 617,671.0 617,671.0
Invesco Ltd. [2023-03-31] DFND 0.0 602,837.0
Goldman Sachs Group Inc [2023-03-31] DFND 516,785.0 556,711.0
First Manhattan Co LLC [2023-03-31] SOLE 437,130.0 447,730.0
Northern Trust Corp [2023-03-31] DFND 19,804.0 410,053.0
WS Management LLLP [2023-03-31] SOLE 396,997.0 396,997.0
American Century Companies Inc [2023-03-31] DFND 380,751.0 380,751.0
Balyasny Asset Management LP [2023-03-31] SOLE 375,608.0 375,608.0
Bank of New York Mellon Corp [2023-03-31] DFND 319,023.0 344,588.0
Morgan Stanley [2023-03-31] DFND 224,654.0 328,565.0
Woodline Partners LP [2023-03-31] SOLE 305,822.0 305,822.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 293,508.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 289,607.0 289,607.0
Principal Financial Group Inc [2023-03-31] DFND 242,026.0 242,026.0
ArchPoint Investors [2023-03-31] SOLE 224,278.0 224,278.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 198,630.0 198,630.0
Bank of America Corp /DE/ [2023-03-31] DFND 8,760.0 198,250.0
Sonic GP LLC [2023-03-31] SOLE 193,079.0 193,079.0
Royce & Associates LP [2023-03-31] SOLE 182,450.0 182,450.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com